Pharmaceuticals

Global Veterinary Vaccines Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-18880203 | Published Date: 11-Aug-2021 | No. of pages: 98

Description

Vaccination is one of the most used applications of modern biotechnology to prevent chronic bacterial, viral and protozoal diseases. Veterinary vaccines are eco-friendly and used to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife.
The Veterinary Vaccines market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Veterinary Vaccines market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Veterinary Vaccines Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Veterinary Vaccines market are:
Bayer Healthcare
Elanco Animal Health
Zoetis
Heska Corporation
Virbac Group
Novartis Animal Health
GE Healthcare
Merck Animal Healthcare
Merial
Boehringer Ingelheim
Nisseiken Co., Ltd
Ceva Animal Health

Most important types of Veterinary Vaccines products covered in this report are:
Livestock Vaccines
Companion Animal Vaccines
Veterinary Vaccines for Diseases
Other Vaccine Types

Most widely used downstream fields of Veterinary Vaccines market covered in this report are:
Companion Animals
Cattle
Pigs
Poultry
Sheep

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.